Form 4: West Pharmaceutical Services Director Deborah Keller Reports Acquisition of Restricted Stock Units

Director Deborah Keller reports the acquisition of 1,071 restricted stock units in West Pharmaceutical Services, Inc.

Summary

• On May 6, 2025, Deborah L. Keller, a director of West Pharmaceutical Services Inc. (WST), reported acquiring 1,071 shares of common stock.
• These shares were received as restricted stock units.
• The restricted stock units were acquired at a price of $0.
• Following the transaction, Keller directly owns 10,656.72 shares of West Pharmaceutical Services Inc.
• The restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and insider confidence.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The restricted stock units will vest in full on the date of the next annual shareholder meeting.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Next Steps

• The restricted stock units will vest at the next annual shareholder meeting.

Key Dates

Keywords

Form 4, Beneficial Ownership, Restricted Stock Units, Director, Deborah L. Keller, West Pharmaceutical Services, WST